Leuprolide is a synthetic analogue of luteinizing hormone-releasing factor, classified as a potent gonadotropin-releasing hormone agonist used clinically to manage prostate cancer in men and conditions… Read more







































Leuprolide is a synthetic analogue of luteinizing hormone-releasing factor, classified as a potent gonadotropin-releasing hormone agonist used clinically to manage prostate cancer in men and conditions such as endometriosis or uterine fibroids in women by suppressing sex hormone production. Our catalogue features a comprehensive range of high-quality reference standards specifically for this drug, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are critical for laboratories performing rigorous analytical testing, impurity profiling, and method validation to ensure the stability, safety, and regulatory compliance of leuprolide formulations. By utilizing these precise reference materials, researchers can accurately identify and quantify degradants and by-products during pharmaceutical quality control processes.